🧪Trial version — For internal lab review only. Not for clinical or production use.
VaxIQ/Polio (IPV/OPV)
← Back to VaxIQ

Polio (IPV/OPV)

Poliovirus Vaccine (Inactivated / Oral)

Tier 1 · EPI/CoreVaccineCuration in progress

Platform: Inactivated / Oral live attenuated

Vaccine that protects against poliovirus, a crippling and potentially fatal infectious disease targeted for global eradication.

poliomucosal immunityeradicationOPVIPV

Immunology Sections

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Wikipedia Overview

Full article ↗
Polio vaccine

Polio vaccine is a vaccine used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.